IL10 and neoplasm: IL-4 and IL-10 are involved in inducing humoral immunity and they play a role in inducing IgG1 antibodies, which mediate complement-dependent cytotoxicity (CDC) and recruit effector cells for antibody-dependent cellular cytotoxicity (ADCC) as a promising antibody isotype for tumor immunotherapy [35,36].